.svg){kind=small}
Adaptive Phase I & II Trials
View service.svg)
Phase III Clinical Studies
View service.svg)
TQT Studies
View service.svg)
Bridging Studies
View service.svg)
Patient Recruitment
View service.svg)
Data Management
View service
Adaptive Phase I & II Trials
View servicePhase III Clinical Studies
View serviceTQT Studies
View serviceBridging Studies
View servicePatient Recruitment
View serviceData Management
View service-min.jpg)
.jpg)
Latest news
Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director
August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read moreRed4Research Blog – Alan’s Story
June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
